Emerald Health Therapeutics Inc (EMH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 321 | 284 | 373 | 279 | 211 |
| Cost of Goods | -91 | -181 | 88 | 476 | 211 |
| Gross Profit | 412 | 465 | 285 | -196 | 0 |
| Operating Expenses | 10,896 | 7,306 | 5,198 | 4,246 | 1,722 |
| Operating Income | -10,484 | -6,841 | -4,913 | -4,442 | -1,722 |
| Other Income | 4,057 | 1,098 | -317 | 415 | -217 |
| Pre-tax Income | -6,427 | -5,744 | -5,230 | -4,028 | -1,939 |
| Income Tax | 0 | -133 | -185 | N/A | N/A |
| Net Income Continuous | -6,427 | -5,611 | -5,045 | -4,028 | -1,939 |
| Minority Interests | 81 | 188 | 137 | N/A | N/A |
| Net Income | $-6,346 | $-5,422 | $-4,908 | $-3,918 | $-1,939 |
| EPS Basic Total Ops | -0.05 | -0.04 | -0.04 | -0.04 | -0.02 |
| EPS Basic Continuous Ops | -0.05 | -0.04 | -0.04 | -0.04 | -0.02 |
| EPS Diluted Total Ops | -0.05 | -0.04 | -0.04 | -0.04 | -0.02 |
| EPS Diluted Continuous Ops | -0.05 | -0.04 | -0.04 | -0.04 | -0.02 |
| EBITDA(a) | $-9,267 | $-5,913 | $-4,664 | $-4,037 | $-1,673 |